Related Experiment Video
Updated: Nov 15, 2025
10:03
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
17.3K
mRNA Vaccines against Flaviviruses.
Clayton J Wollner1, Justin M Richner1
1Department of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, IL 60612, USA.
Vaccines
|March 6, 2021
Summary
Messenger RNA (mRNA) vaccines offer rapid development for emerging pandemics. This review explores mRNA vaccine strategies against diverse flaviviruses, highlighting their potential for combating challenging viral infections.
Area of Science:
- * Virology and Immunology
- * Vaccine Development and Molecular Biology
Background:
- * The messenger RNA (mRNA) platform enables rapid vaccine development, crucial for emerging pandemics.
- * mRNA vaccines function by delivering mRNA encoding viral antigens for exogenous protein expression and immune stimulation.
- * This technology allows for quick adaptation and hypothesis testing against difficult-to-treat viral infections.
Purpose of the Study:
- * To review the development of mRNA vaccines targeting various flaviviruses.
- * To discuss the potential of mRNA technology in addressing flavivirus diseases with pandemic potential.
Main Methods:
- * In vitro synthesis of mRNA encoding specific viral antigens.
- * In vivo delivery of synthesized mRNA into host organisms.
- * Analysis of exogenous protein expression and subsequent immune responses.
Main Results:
- * Successful development of mRNA vaccines against multiple flaviviruses has been demonstrated.
- * The mRNA platform facilitates rapid response to viral threats.
- * Exogenous protein expression leads to robust immune responses.
Conclusions:
- * mRNA vaccines represent a promising approach for combating flavivirus infections.
- * The adaptability of the mRNA platform is key to addressing current and future viral threats.
- * Further research into mRNA vaccines is warranted for flaviviruses and other challenging pathogens.
Related Concept Videos
01:51Vaccinations
49.2K
Overview
49.2K
01:29Viruses with RNA Genomes
369
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
369
01:03Rous Sarcoma Virus (RSV) and Cancer
5.8K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.8K
01:30Cancer Vaccines
619
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
619
01:29Microorganisms in Medicine and Therapeutics
647
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
647